Thiopurine Management Testing for IBD - Mayo Clinic Laboratories
Thiopurine management is important because it can detect individuals with low thiopurinemethyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs.
Genetic liver disease - Insights
Identifying underlying genetic disorders plays an important role in the treatment and care of patients with liver disease. Appropriate use of screening tests in routine clinical practice can rule out possible causes of liver disease and...
Viral Hepatitis Testing - Mayo Clinic Laboratories
At Mayo Clinic, we utilize an algorithmic approach to testing that takes the guesswork out of test ordering to focus on proper test utilization, saving your institution time and money.
Mosquito-borne disease - Insights
View our comprehensive menu of individually orderable tests and panels for mosquito-borne diseases and our algorithmic approach to testing.
Chain of custody drug testing - Insights
Chain of custody testing at Mayo Clinic Laboratories is performed on urine, serum, and meconium and adheres to the highest quality standards to provide secure results.
Comprehensive drug urine profiles - Insights
Able to detect 22 drug classes, our comprehensive addiction medicine profile can help identify polysubstance use disorder as well as assess and manage patients at risk for substance use disorder.
Membranous nephropathy - Insights
Membranous nephropathy (MN) is one of the leading causes of nephrotic syndrome in adults. Our menu of clinically validated assays assists with diagnosis, monitors disease progression, and guides clinical outcomes.
Learn how the pulmonary pathology section at Mayo Clinic Laboratories can provide second-opinion consultations on a broad range of neoplastic and nonneoplastic thoracic cases, including primary ciliary dyskinesia.
Check out Mayo Clinic Laboratories’ full menu of testing for individual drug classes, including benzodiazepines, stimulants, opioids, alcohol, and more.
Accurately characterize marijuana use through urine THC testing - Insights
Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories’ new marijuana monitoring evaluation, which identifies metabolites of both delta-9 tetrahydrocannabinol (THC) and delta-8 THC to accurately identify and...